NAGE
Financials
- Market Capitalization 276.37 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3372 |  IRD Opus Genetics, Inc. - Common Stock | 3.49 USD | -1.97% | -14.88% | -10.74% | -6.18% | 284.07 M USD | ||
| 3383 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 19.72 USD | +3.73% | +4.50% | -14.41% | +94.67% | 289.45 M USD | ||
| 3405 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.62 USD | +0.56% | -3.98% | -7.18% | +29.29% | 276.80 M USD | ||
| 3411 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | 0.00% | +23.95% | +15.00% | 273.31 M USD |
Frequently asked questions about Niagen Bioscience, Inc. - Common Stock
What is the Niagen Bioscience, Inc. - Common Stock stock price today?
The current price of Niagen Bioscience, Inc. - Common Stock (NAGE) is 3.4699999999999998. Over the past 24 hours, the stock has changed by +5.47%. Follow the NAGE chart for real-time price dynamics.
What is the stock ticker of Niagen Bioscience, Inc. - Common Stock?
Niagen Bioscience, Inc. - Common Stock trades under the ticker NAGE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Niagen Bioscience, Inc. - Common Stock stock going up?
NAGE has changed by +2.97% over the last week, -1.42% over the last month, and -30.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Niagen Bioscience, Inc. - Common Stock net income for the last quarter?
Niagen Bioscience, Inc. - Common Stock reported net income of 6.32 M for the last quarter. The previous quarter showed 4.13 M, which means net income changed by +52.90%.
How many employees does Niagen Bioscience, Inc. - Common Stock have?
As of the latest available data, Niagen Bioscience, Inc. - Common Stock has 117 employees. Workforce size can provide additional context about the company's scale and operations.
What is Niagen Bioscience, Inc. - Common Stock EBITDA?
Niagen Bioscience, Inc. - Common Stock EBITDA is 1.87 M, and its EBITDA margin is 5.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Niagen Bioscience, Inc. - Common Stock stock?
You can buy Niagen Bioscience, Inc. - Common Stock (NAGE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Niagen Bioscience, Inc. - Common Stock stock?
Investing in Niagen Bioscience, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NAGE chart and related analysis on metatrader.com as part of your research.